STOCK TITAN

Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Autolus Therapeutics plc (Nasdaq: AUTL) announced its upcoming third quarter 2020 financial results and operational highlights, which will be released before U.S. market opening on November 5, 2020. Management will conduct a conference call at 8:30 AM ET to discuss these results and provide a business update. Interested parties can access the webcast through the company's investor relations page. Details for accessing the call are also provided for both domestic and international callers, along with information for replay after the event.

Positive
  • None.
Negative
  • None.

LONDON, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2020 financial results and operational highlights before open of U.S. markets on Thursday, November 5, 2020.

Management will host a conference call and webcast at 8:30 am ET/1:30 pm GMT to discuss the company’s financial results and provide a general business update. To listen to the webcast and view the accompanying slide presentation, please go to: https://www.autolus.com/investor-relations/news-and-events/events.

The call may also be accessed by dialing (866) 679 5407 for U.S. and Canada callers or (409) 217-8320 for international callers. Please reference conference ID 5562455. After the conference call, a replay will be available for one week. To access the replay, please dial (855) 859-2056 for U.S. and Canada callers or (404) 537-3406 for international callers. Please reference conference ID 5562455.

Contact:

Lucinda Crabtree, PhD
Vice President, Investor Relations and Corporate Communications
+44 (0) 7587 372 619
l.crabtree@autolus.com

Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-212-966-3650
susan@sanoonan.com

FAQ

When will Autolus Therapeutics release its third quarter 2020 financial results?

Autolus Therapeutics will release its third quarter 2020 financial results on November 5, 2020.

What time is the conference call for Autolus Therapeutics' Q3 2020 results?

The conference call will take place at 8:30 AM ET on November 5, 2020.

How can I access the webcast for Autolus Therapeutics' financial results?

You can access the webcast via the Autolus investor relations page.

What is the conference ID for the Autolus Therapeutics conference call?

The conference ID for the call is 5562455.

Autolus Therapeutics plc American Depositary Share

NASDAQ:AUTL

AUTL Rankings

AUTL Latest News

AUTL Stock Data

598.77M
213.36M
18.09%
77.33%
2.35%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
LONDON